Related references
Note: Only part of the references are listed.Stopping Denosumab (vol 17, pg 8, 2019)
Olivier Lamy et al.
CURRENT OSTEOPOROSIS REPORTS (2022)
Cardiovascular Safety and Sclerostin Inhibition
Bente Lomholt Langdahl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Local osteo-enhancement of osteoporotic vertebra with a triphasic bone implant material increases strength-a biomechanical study
Matthias Trost et al.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2020)
Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data
L. -L. Ding et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Treatment of bone loss in proximal femurs of postmenopausal osteoporotic women with AGN1 local osteo-enhancement procedure (LOEP) increases hip bone mineral density and hip strength: a long-term prospective cohort study
J. G. Howe et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Fragility fractures in Europe: burden, management and opportunities
Fredrik Borgstrom et al.
ARCHIVES OF OSTEOPOROSIS (2020)
Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review
D. Cornelissen et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Undertreatment of osteoporosis following hip fracture: a retrospective, observational study in Singapore
Yi Ting Chau et al.
ARCHIVES OF OSTEOPOROSIS (2020)
Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls
Kouta Ito
JAMA NETWORK OPEN (2020)
Guidelines for the management of osteoporosis and fragility fractures
Ranuccio Nuti et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Cost-Effectiveness of Osteoporosis Interventions to Improve Quality of Care After Upper Extremity Fracture: Results From a Randomized Trial (C-STOP Trial)
Sumit R. Majumdar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
In vitro injection of osteoporotic cadaveric femurs with a triphasic calcium-based implant confers immediate biomechanical integrity
John D. Stroncek et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2019)
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment
Serge Ferrari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis
J. -Y. Reginster et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group
J. P. Bilezikian et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
M. Hiligsmann et al.
OSTEOPOROSIS INTERNATIONAL (2019)
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
E. Michael Lewiecki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools
Gloria Bonaccorsi et al.
GYNECOLOGICAL ENDOCRINOLOGY (2018)
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS
A. Svedbom et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS
Axel Svedbom et al.
QUALITY OF LIFE RESEARCH (2018)
Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: A systematic literature review and meta-analysis
Chih-Hsing Wu et al.
BONE (2018)
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
David L. Kendler et al.
LANCET (2018)
Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature
C. -H. Wu et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Characteristics of recurrent fractures
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2018)
The burden and undertreatment of fragility fractures among senior women
Ana M. Rodrigues et al.
ARCHIVES OF OSTEOPOROSIS (2018)
Fracture risk assessment in home care patients using the FRAX (R) tool
Vitor Moraes Rocha et al.
EINSTEIN-SAO PAULO (2018)
EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures
W. F. Lems et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Imminent risk of fracture after fracture
H. Johansson et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Imminent fracture risk
C. Roux et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology
Umberto Tarantino et al.
JOURNAL OF ORTHOPAEDICS AND TRAUMATOLOGY (2017)
Histological and biomechanical effects of zoledronate on fracture healing in an osteoporotic rat tibia model
Mehmet Turker et al.
EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY (2016)
Healing of the bone with anti-fracture drugs
Letizia Vannucci et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture
Serge Ferrari et al.
ARCHIVES OF OSTEOPOROSIS (2016)
Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data
M. Bonafede et al.
ARCHIVES OF OSTEOPOROSIS (2016)
Intravenous zoledronate for osteoporosis: less might be more
Andrew Grey
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2016)
Major osteoporotic fragility fractures: Risk factor updates and societal impact
Paola Pisani et al.
WORLD JOURNAL OF ORTHOPEDICS (2016)
Prophylactic augmentation of the osteoporotic proximal femur-mission impossible?
Peter Varga et al.
BONEKEY REPORTS (2016)
Use of Osteoporosis Medications after Hospitalization for Hip Fracture: A Cross-national Study
Seoyoung C. Kim et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis
Benjamin Z. Leder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw
Mohammad Kharazmi et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Experimental and computational studies on the femoral fracture risk for advanced core decompression
T. N. Tran et al.
CLINICAL BIOMECHANICS (2014)
Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011
Daniel H. Solomon et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis
K. Ganda et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle
K. Akesson et al.
OSTEOPOROSIS INTERNATIONAL (2013)
The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)-quality of life during the first 4 months after fracture
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Clinical risk factors for osteoporosis are common among elderly people in Nuuk, Greenland
Anna Jakobsen et al.
INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH (2013)
Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments
Charles A. Inderjeeth et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
A systematic review of hip fracture incidence and probability of fracture worldwide
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2012)
The burden of osteoporotic fractures beyond acute care: the Canadian Multicentre Osteoporosis Study (CaMos)
Sara Kaffashian et al.
AGE AND AGEING (2011)
Which fractures are most attributable to osteoporosis?
Amy H. Warriner et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Coordinator-based systems for secondary prevention in fragility fracture patients
D. Marsh et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Adverse Effects of Bisphosphonates
Bo Abrahamsen
CALCIFIED TISSUE INTERNATIONAL (2010)
Evidence-based guidelines for the management of hip fractures in older persons: an update
Jenson C. S. Mak et al.
MEDICAL JOURNAL OF AUSTRALIA (2010)
Evidence-based guidelines for the management of hip fractures in older persons: an update
Jenson C. S. Mak et al.
MEDICAL JOURNAL OF AUSTRALIA (2010)
Clinical subsequent fractures cluster in time after first fractures
T. A. C. M. van Geel et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Bisphosphonate-associated adverse events
Peter D. Papapetrou
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture
Veronique Rabenda et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2008)
Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures
Sanjeev Kakar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Compliance with osteoporosis drug therapy and risk of fracture
D. Weycker et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Principles of fixation of osteoporotic fractures
P. V. Giannoudis et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2006)
Current augmentation fixation techniques for the osteoporotic patient
A. Moroni et al.
SCANDINAVIAN JOURNAL OF SURGERY (2006)
Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women
RR Recker et al.
MAYO CLINIC PROCEEDINGS (2005)
Current concepts review bisphosphonates in orthopaedic surgery
CD Morris et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2005)
Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34)
YM Alkhiary et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2005)
Undertreatment with anti-osteoporotic drugs after hospitalization for fracture
MJM Panneman et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Compliance with drug therapies for the treatment and prevention of osteoporosis
JS McCombs et al.
MATURITAS (2004)
The impact of compliance with osteoporosis therapy on fracture rates in actual practice
JJ Caro et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture
SE Andrade et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Hypertension, prevalence and blood pressure levels in 6 European countries, Canada, and the United States
K Wolf-Maier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The burden of osteoporotic fractures: A method for setting intervention thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Long-term risk of osteoporotic fracture in Malmo
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Share Paper
